Association of the platelet-to-high-density lipoprotein cholesterol ratio (PHR) with metabolic syndrome and metabolic overweight/obesity phenotypes: A study based on the Dryad database
database[Title] 2025-05-13
Summary:
CONCLUSION: PHR demonstrates strong associations with MetS, MHO, and MUO, indicating its potential utility as an early biomarker for metabolic dysfunction.